[ad_1] Abbott Laboratories (ABT) enjoyed a third-quarter beat, partly due to its Covid testing division. But those sales are expected to peter out, and so ABT stock slumped. X Through the end of the third quarter, Abbott Labs amassed $7.3 billion in sales of its Covid tests. As a result, third-quarter sales declined less than